Go Pro
NASDAQ:SMTI

Sanara MedTech Q2 2026 Earnings Report

Sanara MedTech logo
$35.15 -0.13 (-0.37%)
Closing price 04:00 PM Eastern
Extended Trading
$35.14 -0.01 (-0.03%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sanara MedTech EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.03
One Year Ago EPS
N/A

Sanara MedTech Revenue Results

Actual Revenue
$28.14 million
Expected Revenue
$28.95 million
Beat/Miss
Missed by -$813.24 thousand
YoY Revenue Growth
N/A

Sanara MedTech Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Tuesday, August 11, 2026
Conference Call Time
4:00PM ET

Upcoming Earnings

Sanara MedTech's Q3 2026 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Sanara MedTech Earnings Headlines

Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Sanara MedTech Inc
See More Sanara MedTech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sanara MedTech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanara MedTech and other key companies, straight to your email.

About Sanara MedTech

Sanara MedTech (NASDAQ:SMTI) is a medical technology company focused on developing and commercializing products for wound care, surgical reconstruction and tissue repair. Its portfolio is designed to support the management of chronic, acute and surgical wounds across a range of clinical settings.

The company’s products include advanced wound matrices, collagen-based products, tissue-repair grafts and antimicrobial solutions. Its offerings include the CellerateRX line of collagen products, BIAKOS antimicrobial wound-care products, Restrata synthetic wound matrices and FORTIFY tissue-repair grafts. These products are intended for use by healthcare professionals in hospitals, outpatient facilities, wound-care centers and other treatment environments.

Sanara MedTech is headquartered in Fort Worth, Texas, and primarily serves the United States through commercial and distribution relationships. The company’s strategy is centered on expanding access to regenerative and advanced wound-care technologies while building a portfolio of products for complex wound-management and surgical applications.

View Sanara MedTech Profile